Zikani Therapeutics is a new anti-infective company founded to advance groundbreaking technology. Founded by Andrew G. Myers and Lawrence G. Miller in 2014, Zikani Therapeutics is backed by investors that include Advent Life Sciences, Gurnet Point Capital, and Roche Venture Fund and is headquartered in Newton.